ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,146, issued on Oct. 21, was assigned to MC2 Therapeutics Ltd. (Letherhead, Great Britain).
"Topical composition comprising tacrolimus" was invented by Nigel Crutchley (Letherhead, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition for topical application comprising: a first discontinuous phase comprising a first oil and tacrolimus; a second discontinuous phase comprising a second oil; and a continuous aqueous phase; wherein the first oil is different from the second oil."
The patent was filed on May 23, 2022, under Application No. 17/750,836.
*For further information, including images, chart...